TD Ameritrade Investment Management’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-37
Closed -$3K 98
2023
Q2
$3K Sell
37
-23
-38% -$1.55K ﹤0.01% 424
2023
Q1
$4K Hold
60
﹤0.01% 433
2022
Q4
$4K Sell
60
-5
-8% -$358 ﹤0.01% 439
2022
Q3
$4K Sell
65
-600
-90% -$45.9K ﹤0.01% 438
2022
Q2
$47K Sell
665
-328
-33% -$26.4K ﹤0.01% 304
2022
Q1
$91K Sell
993
-17
-2% -$1.6K ﹤0.01% 306
2021
Q4
$102K Buy
+1,010
New +$103K ﹤0.01% 288
2021
Q3
Sell
-939
Closed -$97K 650
2021
Q2
$97K Buy
939
+339
+57% +$34.5K ﹤0.01% 284
2021
Q1
$56K Hold
600
﹤0.01% 321
2020
Q4
$56K Buy
+600
New +$52.8K ﹤0.01% 321

Other funds holding CRI

TD Ameritrade Investment Management's CRI Position: Q3 2023 in Review

TD Ameritrade Investment Management sold out of Carter's (CRI) in Q3 2023, closing a stake of 37 shares — an estimated $3K sold.

TD Ameritrade Investment Management first reported a position in CRI in Q4 2020 and held it in 10 quarters. The position peaked at $102K in Q4 2021. 301 funds tracked by Wall St. Rank hold CRI as of Q3 2023.

  • TD Ameritrade Investment Management reported no remaining Carter's position as of Q3 2023 after selling out during the quarter.
  • TD Ameritrade Investment Management sold 37 Carter's shares in Q3 2023, an estimated $3K.
  • TD Ameritrade Investment Management first reported a position in Carter's in Q4 2020 and held it in 10 quarters.
  • TD Ameritrade Investment Management's Carter's position peaked at $102K in Q4 2021.
  • 301 funds tracked by Wall St. Rank held Carter's as of Q3 2023.

Based on TD Ameritrade Investment Management's 13F filing for Q3 2023.